ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.

Saved in:
Bibliographic Details
Title: ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
Authors: Piotrowska Z; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Voon PJ; Radiotherapy and Oncology Department, Hospital Umum Sarawak, Kuching, Malaysia., Pang YK; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., How SH; Department of Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Malaysia., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Cortinovis D; Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University Milano-Bicocca, Milan, Italy., de Castro Carpeño J; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC, IdiPAZ, Madrid, Spain., Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Rodríguez Abreu D; Department of Medical Oncology, Gran Canaria University Hospital, Las Palmas de Gran Canaria, Spain., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Li J; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland., Servidio L; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland., Taylor R; Oncology Biometrics, AstraZeneca (United Kingdom), Macclesfield, United Kingdom., Hartmaier R; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Markovets AA; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Tang KH; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Source: Cancer discovery [Cancer Discov] 2026 Jun 01; Vol. 16 (6), pp. 1074-1086.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-25-0960